CN104398399A - Composite glycopeptide breast beauty cream and preparation method thereof - Google Patents
Composite glycopeptide breast beauty cream and preparation method thereof Download PDFInfo
- Publication number
- CN104398399A CN104398399A CN201410647968.3A CN201410647968A CN104398399A CN 104398399 A CN104398399 A CN 104398399A CN 201410647968 A CN201410647968 A CN 201410647968A CN 104398399 A CN104398399 A CN 104398399A
- Authority
- CN
- China
- Prior art keywords
- breast
- parts
- protein peptide
- peptide
- glycopeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a composite glycopeptide breast beauty cream, which is prepared from the following raw materials by weight: 0.1-0.5 part of sheep placenta protein peptide, 0.01-0.5 part of Oviductus Ranae small molecular peptide, 0.05-0.5 part of royal jelly protein peptide, 0.2-1.0 part of collagen peptide, 2-20 parts of biological polysaccharide, 2-20 parts of a transdermal enhancer, 5-30 parts of an emulsifier, 0.5-30 parts of a humectants, and 50-80 parts of water. By using the small molecular peptide and plant essence, and with the help of the transdermal enhancer, transdermal absorption of functional substances can be promoted, thus reaching the purposes of breast enhancement and beautification.
Description
Technical field
The present invention relates to a kind of not containing the U.S. milk product of gonadal hormone, particularly a kind of compound glycopeptide breast cream and preparation method thereof, belongs to cosmetic technical field.
Background technology
Breast tissue 1/3 is mammary gland, and 2/3 is fat, and suitable nutrient can provide various nutritional labeling for breast development, increases the fat in breast; Appropriate various U.S. milk composition can bring out and urge mammary gland secretion function, serum estrogen level in improving, and effectively makes flat breast, microemulsion protuberance plentiful, makes to relax, pendulous udder recovers normal.
Owing to forbidding gonadal hormone to be added the U.S. breast cosmetics of breast enlargement both at home and abroad, present U.S.'s breast additive, mostly is animals and plants extract and bioactive substance.As pollen extract, the Chinese herbal medicine extract such as Radix Salviae Miltiorrhizae, Flos Carthami, hydrolysis placental protein, Lac regis apis albumen (Lac regis apis albumen), collagen protein, Oviductus Ranae albumen etc.The extract of animal origin or active component, mostly be protein.But at present, effect is all limited.
Summary of the invention
The present invention first object is to provide a kind of compound glycopeptide breast cream, the Transdermal absorption of its energy promotion functions material, effectively improves the U.S. newborn effect of breast enlargement.
To achieve these goals, the present invention adopts following technical scheme:
A kind of compound glycopeptide breast cream, the raw material comprising following weight portion obtains: Placenta caprae seu ovis protein peptide 0.1-0.5 part, Oviductus Ranae small-molecular peptides 0.01-0.5 part, Lac regis apis protein peptide 0.05-0.5 part, collagen peptide 0.2-1.0 part, biological polyoses 2-20 part, transdermal enhancer 2-20 part, emulsifying agent 5-30 part, wetting agent 0.5-30 part, water 50-80 part.Adopt breast cream of the present invention, effectively can promote that the infiltration of active component absorbs, effectively improve the U.S. newborn effect of breast enlargement.
Preferably, the raw material that described compound glycopeptide breast cream comprises following weight portion obtains: Placenta caprae seu ovis protein peptide 0.1-0.5 part, Oviductus Ranae small-molecular peptides 0.01-0.5 part, Lac regis apis protein peptide 0.05-0.5 part, collagen peptide 0.2-1.0 part, biological polyoses 5-15 part, transdermal enhancer 5-15 part, emulsifying agent 10-20 part, wetting agent 5-15 part, water 50-80 part.
The U.S. curdling glue of complex polypeptide of the present invention also can containing anti-corruption dose.Described antiseptic be selected from Nipagin ester, thimerosal, chlorocresol, chlorobutanol, benzoic acid and sodium benzoate one or more.
As the preferred embodiment of the present invention, described compound glycopeptide breast cream, is obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.1-0.5 part; Oviductus Ranae small-molecular peptides 0.01-0.5 part; Lac regis apis protein peptide 0.05-0.5 part; Collagen peptide 0.2-1.0 part; Trehalose 1-5 part; Avenabeta glucosan 0.5-5 part; α-mannan 0.5-5 part; Hyaluronic acid 0.2-2 part; Spermol 2-5 part; Isopropyl palmitate 4-7 part; Polyethylene Glycol coco glycerides 0.5-5 part; TranscultolP 5-15 part; Glycerol 5-15 part; Water 50-80 part; Nipagin ester 0.005 part;
Or described compound glycopeptide breast cream, is obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.1-0.5 part; Oviductus Ranae small-molecular peptides 0.01-0.5 part; Lac regis apis protein peptide 0.05-0.5 part; Collagen peptide 0.2-1.0 part; Trehalose 1-5 part; Avenabeta glucosan 0.5-5 part; Spermol 2-5 part; Isopropyl palmitate 4-7 part; Polydimethylsiloxane 0.3-3 part; TranscultolP 5-15 part; Glycerol 5-15 part; Water 50-80 part; Nipagin ester 0.005 part.
As the present invention further preferred embodiment, described compound glycopeptide breast cream, is obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.02 part; Oviductus Ranae small-molecular peptides 0.5 part; Lac regis apis protein peptide 0.5 part; Collagen peptide 1.0 parts; Trehalose 3 parts; Avenabeta glucosan 4 parts; α-mannan 3 parts; Hyaluronic acid 0.2 part; Spermol 2.5 parts; Isopropyl palmitate 4 parts; Polyethylene Glycol sodium cocoglyceryl 1 part; Transcultol P 10 parts; Glycerol 10 parts; 60.275 parts, water; Nipagin ester 0.005 part.
Or described compound glycopeptide breast cream, is obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.5 part; Oviductus Ranae small-molecular peptides 0.1 part; Lac regis apis protein peptide 0.25 part; Collagen peptide 0.2 part; Trehalose 5 parts; Avenabeta glucosan 3 parts; Spermol 4 parts; Isopropyl palmitate 6 parts; Polydimethylsiloxane 2 parts; Transcultol P 10 parts; Glycerol 8 parts; 60.954 parts, water; Nipagin ester 0.005 part.
As another optimal way of the present invention, described compound glycopeptide breast cream, is obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.02-0.5 part; Oviductus Ranae small-molecular peptides 0.1-0.5 part; Lac regis apis protein peptide 0.25-0.5 part; Collagen peptide 0.2-1.0 part; Biological polyoses 8-11 part, transdermal enhancer 9-10 part, emulsifying agent 7-12 part, wetting agent 8-10 part, water 59-61 part, antiseptic 0.005 part.
Further preferably, described compound glycopeptide breast cream, is obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.02-0.03 part; Oviductus Ranae small-molecular peptides 0.4-0.5 part; Lac regis apis protein peptide 0.4-0.5 part; Collagen peptide 0.9-1.0 part; Biological polyoses 10-11 part, transdermal enhancer 9-10 part, emulsifying agent 7-8 part, wetting agent 9-10 part, water 59-61 part, antiseptic 0.005 part;
In the present invention, the molecular weight of described Placenta caprae seu ovis protein peptide, Oviductus Ranae small-molecular peptides, Lac regis apis protein peptide and collagen peptide is all less than 5000 dalton; Preferably between 300-1500 dalton.By protein peptide being impelled better to enter skin to the concrete selection of molecular weight, thus play effect to greatest extent.
In the present invention, described biological polyoses is selected from one or more in trehalose, avenabeta glucosan, α-mannan, hyaluronic acid.Select suitable biological polyoses not to be only breast and provide sugared composition, being conducive to mammary fat increases; Simultaneously with multiple protein peptide compatibility, serum estrogen level in improving, effectively improves mammary contour, impels breast enlargement.
In the present invention, described transdermal enhancer is selected from azone and/or TC (Transcultol P); Preferred TC (Transcultol P), it can effectively impel active component to infiltrate skin fast, ensures the performance of its effect to greatest extent.
In the present invention, described emulsifying agent is selected from one or more in phospholipid, tween, span, polyoxyethylene castor oil, polyoxyethylene hydrogenated Oleum Ricini, tocofecol succinic acid macrogol ester, spermol, isopropyl palmitate, Polyethylene Glycol coco glycerides, caprylic/capric triglyceride, polydimethylsiloxane.Preferred spermol, isopropyl palmitate, Polyethylene Glycol coco glycerides, polydimethylsiloxane.
In the present invention, described wetting agent is selected from propylene glycol and/or glycerol; Preferably glycerine.
The present invention second object is to provide a kind of preparation method of compound glycopeptide breast cream, comprises the steps:
1) in proportion Placenta caprae seu ovis protein peptide, Oviductus Ranae small-molecular peptides, Lac regis apis protein peptide, collagen peptide, biological polyoses, wetting agent, transdermal enhancer are added to the water, stir refrigerant mixture, for subsequent use;
2) emulsifying agent is added in mixture, stir, obtain compound glycopeptide breast cream.
Or in step 2, emulsifying agent and antiseptic are mixed under 50-70 DEG C of condition, adds again in mixture after being down to room temperature.
Beneficial effect of the present invention:
Complex polypeptide and biological polyoses are applied in U.S. milk product by the present invention first, by selecting protein peptide and the plant essence of applicable molecular weight, by the Transdermal absorption of cutaneous permeable agent promotion functions material, realize the object of the U.S. breast of quick breast enlargement.U.S. milk product of the present invention is not containing gonadal hormone, and safety, effectively, is applicable to promoting the use of.
Detailed description of the invention
Below in conjunction with embodiment, embodiment of the present invention are described in detail, but it will be understood to those of skill in the art that the following example only for illustration of the present invention, and should not be considered as limiting scope of the present invention.Unreceipted actual conditions person in embodiment, the condition of conveniently conditioned disjunction manufacturer suggestion is carried out.Agents useful for same or the unreceipted production firm person of instrument, being can by the conventional products of commercial acquisition.
Embodiment 1 one kinds of compound glycopeptide breast creams (containing antiseptic)
Formula is as table 1.Embodiment 1 is the embodiment of best results of the present invention.
Table 1
| Material name | Quality (g) |
| Placenta caprae seu ovis protein peptide (molecular weight 100 dalton) | 0.02 |
| Oviductus Ranae small-molecular peptides (molecular weight 1500 dalton) | 0.5 |
| Lac regis apis protein peptide (molecular weight 900 dalton) | 0.5 |
| Collagen peptide (molecular weight 400 dalton) | 1.0 |
| Trehalose | 3 |
| Avenabeta glucosan | 4 |
| α-mannan | 3 |
| Hyaluronic acid | 0.2 |
| Spermol | 2.5 |
| Isopropyl palmitate | 4 |
| Polyethylene Glycol coco glycerides | 1 |
| Transcultol P | 10 |
| Glycerol | 10 |
| Water | 60.275 |
| Nipagin ester | 0.005 |
Embodiment 2 one kinds of compound glycopeptide breast creams (containing antiseptic)
Formula is as table 2.
Table 2
| Material name | Quality (g) |
| Placenta caprae seu ovis protein peptide (molecular weight 100 dalton) | 0.5 |
| Oviductus Ranae small-molecular peptides (molecular weight 1500 dalton) | 0.1 |
| Lac regis apis protein peptide (molecular weight 900 dalton) | 0.25 |
| Collagen peptide (molecular weight 400 dalton) | 0.2 |
| Trehalose | 5 |
| Avenabeta glucosan | 3 |
| Spermol | 4 |
| Isopropyl palmitate | 6 |
| Polydimethylsiloxane | 2 |
| Transcultol P | 10 |
| Glycerol | 8 |
| Water | 60.954 |
| Thimerosal | 0.005 |
Embodiment 3 one kinds of compound glycopeptide breast creams (containing antiseptic)
Formula is as table 3.
Table 3
| Material name | Quality (g) |
| Placenta caprae seu ovis protein peptide (molecular weight 300 dalton) | 0.3 |
| Oviductus Ranae small-molecular peptides (molecular weight 800 dalton) | 0.2 |
| Lac regis apis protein peptide (molecular weight 1000 dalton) | 0.4 |
| Collagen peptide (molecular weight 700 dalton) | 0.5 |
| Trehalose | 5 |
| Avenabeta glucosan | 5 |
| Spermol | 3 |
| Isopropyl palmitate | 4 |
| Polydimethylsiloxane | 3 |
| Transcultol P | 9 |
| Glycerol | 9 |
| Water | 61 |
| Chlorocresol | 0.005 |
Embodiment 4 one kinds of compound glycopeptide breast creams (not containing antiseptic)
Embodiment 4 formula and embodiment 1 formula are distinguished and are not containing antiseptic, trehalose, and spermol is replaced with tween.
Embodiment 5 one kinds of compound glycopeptide breast creams (not containing antiseptic)
Embodiment 5 formula and embodiment 2 formula are distinguished and are not containing antiseptic, and isopropyl palmitate, polydimethylsiloxane are replaced with span, polyoxyethylene castor oil.
Embodiment 6 one kinds of compound glycopeptide breast creams (not containing antiseptic)
Embodiment 6 formula and embodiment 3 formula are distinguished and are not containing antiseptic, and Transcultol P, glycerol are replaced with azone, propylene glycol.
Embodiment 7 one kinds of compound glycopeptide breast creams (not containing antiseptic)
Embodiment 7 formula and embodiment 4 are distinguished and are, transdermal enhancer is selected from azone; Emulsifying agent is selected from phospholipid, polyoxyethylene castor oil, tocofecol succinic acid macrogol ester; Wetting agent is selected from propylene glycol.
The preparation method of embodiment 8 one kinds of compound glycopeptide breast creams
Described in embodiment 1, a preparation method for compound glycopeptide breast cream, comprises the steps:
1) in proportion Placenta caprae seu ovis protein peptide, Oviductus Ranae small-molecular peptides, Lac regis apis protein peptide, collagen peptide, biological polyoses, wetting agent, transdermal enhancer are added to the water, stir refrigerant mixture, for subsequent use;
2) emulsifying agent and antiseptic are mixed under 50-70 DEG C of condition, add again in mixture after being down to room temperature, stir, obtain compound glycopeptide breast cream.
The preparation method of embodiment 9 one kinds of compound glycopeptide breast creams
Adopt method described in embodiment 8 to prepare embodiment 4-6 compound glycopeptide breast cream, difference is, step 2) in through emulsifying agent is added in mixture, stir, obtain compound glycopeptide breast cream.
Compliance test result
Experimental example 1, different composite glycopeptide breast cream breast enlargement Effect disquisition
Sample: embodiment 1-7 gained cream product.
Reference substance 1: the formula and the preparation method that adopt embodiment 1, wherein will replace with pine pollen polysaccharide, lycium barbarum polysaccharide, Auricularia polycose by biological polyoses simultaneously.
Reference substance 2: four protein peptide are replaced with commercially available molecular weight at the daltonian Placenta caprae seu ovis protein peptide of 5500-7000, Oviductus Ranae small-molecular peptides, Lac regis apis protein peptide, collagen peptide by the formula and the preparation method that adopt embodiment 1 simultaneously.
Reference substance 3: the formula and the preparation method that adopt embodiment 1, replace with Conventional transdermal promoter dimethyl sulfoxide by transdermal enhancer Transcutol P simultaneously.
Effectiveness indicator: safety, breast elevation carrection, breast elastic force are measured, responding time.
Testing program: with reference to " U.S. newborn class cosmetics human safety and U.S.'s breast effect detection method ".
Choose in process of the test 35-45 year normal female experimenter 100, be divided into 10 groups at random, often organize 10, use embodiment 1-7 and reference substance 1-3 respectively, use every night 1 time, be evenly applied to chest breast, use 5 weeks continuously.Subject enrollment standard is: without serious systemic performance disease, without gynaecopathia and without anaphylactic disease, do not accept the plastic operation person that enlarges the bosom, breast portion skin is normal, any anti-inflammatory drug person is not used in nearly one week local, do not participated in other U.S. newborn class cosmetics clinical trial persons in nearly one month, voluntary participation is tested.
Breast increases criterion:
Excellent: compared with before use, breast height increases more than 9.5mm;
Effective: compared with before use, breast height is increased between 7.5mm ~ 9.5mm;
Effective: compared with before use, breast height increases between 5.0mm ~ 7.5mm;
Invalid: compared with before use, breast height increases below 5.0mm.
The criterion of breast force variation:
Excellent: compared with before use, elastic force increases more than 7.5mm;
Effective: compared with before use, elastic force increases between 5.5mm ~ 7.5mm;
Effective: compared with before use, breast elastic force increases between 3.0mm ~ 5.5mm;
Invalid: compared with before use, breast elastic force increases below 3.0mm.
Result of the test is as shown in the table.
Table 1 safety research
Table 2 breast increases effect
| Splendid | Effective | Effectively | Invalid | |
| Embodiment 1 | 6 | 2 | 1 | 1 |
| Embodiment 2 | 4 | 1 | 3 | 2 |
| Embodiment 3 | 5 | 1 | 3 | 1 |
| Embodiment 4 | 4 | 2 | 2 | 2 |
| Embodiment 5 | 2 | 2 | 3 | 3 |
| Embodiment 6 | 3 | 2 | 3 | 2 |
| Embodiment 7 | 2 | 2 | 3 | 3 |
| Reference substance 1 | 1 | 2 | 4 | 3 |
| Reference substance 2 | 1 | 3 | 3 | 3 |
| Reference substance 3 | 1 | 2 | 3 | 4 |
Table 3 breast elasticity effect
| Splendid | Effective | Effectively | Invalid | |
| Embodiment 1 | 7 | 2 | 1 | 0 |
| Embodiment 2 | 5 | 2 | 2 | 1 |
| Embodiment 3 | 6 | 2 | 2 | 0 |
| Embodiment 4 | 5 | 2 | 2 | 1 |
| Embodiment 5 | 3 | 3 | 3 | 1 |
| Embodiment 6 | 4 | 2 | 2 | 2 |
| Embodiment 7 | 3 | 2 | 2 | 3 |
| Reference substance 1 | 2 | 3 | 3 | 2 |
| Reference substance 2 | 1 | 3 | 4 | 2 |
| Reference substance 3 | 1 | 4 | 3 | 2 |
Table 4 responding time
As can be seen from result, sample and reference substance safety high, be free from side effects after using, skin is generally smooth.From effectiveness, breast increases effective percentage, breast elastic force increases effective percentage and responding time, and sample sets is all higher than matched group.As can be seen here, by selecting protein peptide and the plant essence of applicable molecular weight, by the Transdermal absorption of cutaneous permeable agent promotion functions material, realize the object of the U.S. breast of quick breast enlargement.
Although above the present invention is described in detail with a general description of the specific embodiments, on basis of the present invention, can make some modifications or improvements it, this will be apparent to those skilled in the art.Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, all belong to the scope of protection of present invention.
Claims (10)
1. a compound glycopeptide breast cream, it is characterized in that, the raw material comprising following weight portion obtains: Placenta caprae seu ovis protein peptide 0.1-0.5 part, Oviductus Ranae small-molecular peptides 0.01-0.5 part, Lac regis apis protein peptide 0.05-0.5 part, collagen peptide 0.2-1.0 part, biological polyoses 2-20 part, transdermal enhancer 2-20 part, emulsifying agent 5-30 part, wetting agent 0.5-30 part, water 50-80 part.
2. compound glycopeptide breast cream according to claim 1, is characterized in that, obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.02-0.5 part; Oviductus Ranae small-molecular peptides 0.1-0.5 part; Lac regis apis protein peptide 0.25-0.5 part; Collagen peptide 0.2-1.0 part; Biological polyoses 8-11 part, transdermal enhancer 9-10 part, emulsifying agent 7-12 part, wetting agent 8-10 part, water 59-61 part, antiseptic 0.005 part.
3. compound glycopeptide breast cream according to claim 1, is characterized in that, obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.02-0.03 part; Oviductus Ranae small-molecular peptides 0.4-0.5 part; Lac regis apis protein peptide 0.4-0.5 part; Collagen peptide 0.9-1.0 part; Biological polyoses 10-11 part, transdermal enhancer 9-10 part, emulsifying agent 7-8 part, wetting agent 9-10 part, water 59-61 part, antiseptic 0.005 part.
4., according to the arbitrary described compound glycopeptide breast cream of claim 1-3, it is characterized in that, the molecular weight of described Placenta caprae seu ovis protein peptide, Oviductus Ranae small-molecular peptides, Lac regis apis protein peptide and collagen peptide is all less than 5000 dalton; Preferably between 300-1500 dalton.
5., according to the arbitrary described compound glycopeptide breast cream of claim 1-3, it is characterized in that, described biological polyoses be selected from trehalose, avenabeta glucosan, α-mannan, hyaluronic acid one or more.
6., according to the arbitrary described compound glycopeptide breast cream of claim 1-3, it is characterized in that, described transdermal enhancer is selected from azone and/or TC; Preferred TC.
7. according to the arbitrary described compound glycopeptide breast cream of claim 1-3, it is characterized in that, described emulsifying agent be selected from phospholipid, tween, span, polyoxyethylene castor oil, polyoxyethylene hydrogenated Oleum Ricini, tocofecol succinic acid macrogol ester, spermol, isopropyl palmitate, Polyethylene Glycol coco glycerides, caprylic/capric triglyceride, polydimethylsiloxane one or more; Preferred spermol, isopropyl palmitate, Polyethylene Glycol coco glycerides, polydimethylsiloxane.
8., according to the arbitrary described compound glycopeptide breast cream of claim 1-3, it is characterized in that, described wetting agent is selected from propylene glycol and/or glycerol; Preferably glycerine.
9. compound glycopeptide breast cream according to claim 1, is characterized in that, obtained by the raw material of following weight portion: Placenta caprae seu ovis protein peptide 0.02 part; Oviductus Ranae small-molecular peptides 0.5 part; Lac regis apis protein peptide 0.5 part; Collagen peptide 1.0 parts; Trehalose 3 parts; Avenabeta glucosan 4 parts; α-mannan 3 parts; Hyaluronic acid 0.2 part; Spermol 2.5 parts; Isopropyl palmitate 4 parts; Polyethylene Glycol sodium cocoglyceryl 1 part; Transcultol P 10 parts; Glycerol 10 parts; 60.275 parts, water; Nipagin ester 0.005 part.
10. a preparation method for the arbitrary described compound glycopeptide breast cream of claim 1-9, is characterized in that, comprise the steps:
1) in proportion Placenta caprae seu ovis protein peptide, Oviductus Ranae small-molecular peptides, Lac regis apis protein peptide, collagen peptide, biological polyoses, wetting agent, transdermal enhancer are added to the water, stir refrigerant mixture, for subsequent use;
2) emulsifying agent is added in mixture, stir, obtain compound glycopeptide breast cream;
Or in step 2, emulsifying agent and antiseptic are mixed under 50-70 DEG C of condition, adds again in mixture after being down to room temperature.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410647968.3A CN104398399A (en) | 2014-11-14 | 2014-11-14 | Composite glycopeptide breast beauty cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410647968.3A CN104398399A (en) | 2014-11-14 | 2014-11-14 | Composite glycopeptide breast beauty cream and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104398399A true CN104398399A (en) | 2015-03-11 |
Family
ID=52636112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410647968.3A Pending CN104398399A (en) | 2014-11-14 | 2014-11-14 | Composite glycopeptide breast beauty cream and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104398399A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107212378A (en) * | 2016-03-22 | 2017-09-29 | 内蒙古伊利实业集团股份有限公司 | A kind of function composition with regulation enteron aisle and its application |
| CN107854594A (en) * | 2017-12-01 | 2018-03-30 | 广州圣芳医药科技有限公司 | A kind of composition with function of breast augmentation |
| CN108338934A (en) * | 2017-01-23 | 2018-07-31 | 珠海联邦制药股份有限公司 | A kind of peptide composition and its application for eye-care |
| CN109662939A (en) * | 2019-03-05 | 2019-04-23 | 瑙ｄ腹 | A kind of newborn composition of chest enlarge U.S., chest enlarge breast cream and preparation method thereof |
| CN113749968A (en) * | 2021-10-26 | 2021-12-07 | 奥易生物科技(杭州)有限公司 | Cosmetic capable of being quickly absorbed through skin and preparation method thereof |
| EP4169502A1 (en) | 2021-10-22 | 2023-04-26 | Provital, S.A.U. | Cosmetic and dermatological use of rubus fruticosus fruit extract |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309421A (en) * | 2010-07-07 | 2012-01-11 | 吉林博大农林生物科技有限公司 | Method for processing snow frog oil essential breast beautifying cream |
| CN102329827A (en) * | 2011-07-12 | 2012-01-25 | 湖州康海斯生物科技有限公司 | Sheep placenta amino acid and low molecular weight polypeptide, and preparation method for sheep placenta amino acid and low molecular weight polypeptide |
| CN103305580A (en) * | 2013-07-03 | 2013-09-18 | 广州金娜宝生物科技有限公司 | Method for preparing collagen peptide from mammal skin and bone |
-
2014
- 2014-11-14 CN CN201410647968.3A patent/CN104398399A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309421A (en) * | 2010-07-07 | 2012-01-11 | 吉林博大农林生物科技有限公司 | Method for processing snow frog oil essential breast beautifying cream |
| CN102329827A (en) * | 2011-07-12 | 2012-01-25 | 湖州康海斯生物科技有限公司 | Sheep placenta amino acid and low molecular weight polypeptide, and preparation method for sheep placenta amino acid and low molecular weight polypeptide |
| CN103305580A (en) * | 2013-07-03 | 2013-09-18 | 广州金娜宝生物科技有限公司 | Method for preparing collagen peptide from mammal skin and bone |
Non-Patent Citations (2)
| Title |
|---|
| 吴秀英: "《美乳及美乳化妆品》", 《中国妇女报》 * |
| 肖子英: "《第五讲 美乳化妆品全成分标注》", 《中国化妆品（行业）》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107212378A (en) * | 2016-03-22 | 2017-09-29 | 内蒙古伊利实业集团股份有限公司 | A kind of function composition with regulation enteron aisle and its application |
| CN108338934A (en) * | 2017-01-23 | 2018-07-31 | 珠海联邦制药股份有限公司 | A kind of peptide composition and its application for eye-care |
| CN107854594A (en) * | 2017-12-01 | 2018-03-30 | 广州圣芳医药科技有限公司 | A kind of composition with function of breast augmentation |
| CN109662939A (en) * | 2019-03-05 | 2019-04-23 | 瑙ｄ腹 | A kind of newborn composition of chest enlarge U.S., chest enlarge breast cream and preparation method thereof |
| EP4169502A1 (en) | 2021-10-22 | 2023-04-26 | Provital, S.A.U. | Cosmetic and dermatological use of rubus fruticosus fruit extract |
| CN113749968A (en) * | 2021-10-26 | 2021-12-07 | 奥易生物科技(杭州)有限公司 | Cosmetic capable of being quickly absorbed through skin and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104398399A (en) | Composite glycopeptide breast beauty cream and preparation method thereof | |
| AU2005294805B2 (en) | A mixture for transdermal delivery of low and high molecular weight compounds | |
| CN104856928A (en) | Anti-wrinkle and anti-aging cosmetic and preparation method thereof | |
| IL260028B2 (en) | Skin care preparations for babies | |
| CN1883449A (en) | A cosmetic composition and preparation method thereof | |
| CN103505403B (en) | Epidermal growth factor composite liposome body and its preparation method and application | |
| CN105012479A (en) | Acne treatment composition and application thereof and acne treatment cream containing acne treatment composition | |
| KR20150009521A (en) | Topical Dermal Formulations and Methods of Personalized Treatment of Skin | |
| CN109568169A (en) | A kind of active peptides of tool hair growth effect | |
| CN104434768A (en) | Moisturizing lotion with slow-release efficacy and preparation method of moisturizing lotion | |
| CN105796459A (en) | Moisturizing gel containing hydrolyzed pearl powder flexible nano liposome | |
| CN105616221A (en) | Acne-removal cosmetic and preparation method thereof | |
| CN106389139A (en) | Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof | |
| CN112022895A (en) | Composition for skin barrier repair and preparation method thereof | |
| CN104323948A (en) | Spot removing compound essential oil | |
| CN1875920B (en) | Recombinant human serum albumin and yeast ferment mixture, composition containing said mixture, preparation process and use thereof | |
| CA2540539A1 (en) | A mixture for transdermal delivery of low and high molecular weight compounds comprising an ethoxylated oil | |
| CN103816083B (en) | A kind of pox-dispelling function transparency emulsion containing basic fibroblast growth factor and preparation method thereof | |
| KR20190063422A (en) | Dermatologic composition containing escherichia coli and enterococcus faecalis | |
| CN105193694A (en) | Skin care product with whitening and freckle-removing functions | |
| CN105310972A (en) | Anti-wrinkle skin care product | |
| CN105749213A (en) | Plant internal-regulation breast membrane and preparation method thereof | |
| US20110002883A1 (en) | Therapeutic preparations containing wharton's jelly | |
| CN108451863A (en) | A kind of 48 hours facial treatment essence water of long-acting moisturizing | |
| CN111358710A (en) | Moisture-preserving and soothing donkey-hide gelatin face cream and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150311 |
|
| RJ01 | Rejection of invention patent application after publication |